Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Kulkarni · SciRah

Researcher profile · Semantic Scholar

A. Kulkarni

Share profile

A. Kulkarni — researcher profile on SciRah

h-index: 15
Works: 37
Citations: 1,141

Most-cited papers

Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
J. Francis, Adam Kiezun, A. Ramos, S. Serra +43 more
2013Nature Genetics329 citations Open access
Semantic Scholar
The genomic landscape of small intestine neuroendocrine tumors.
Michaela S. Banck, R. Kanwar, A. Kulkarni, Ganesh K. Boora +14 more
2013Journal of Clinical Investigation297 citations Open access
Semantic Scholar
Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines.
Ganesh K. Boora, R. Kanwar, A. Kulkarni, Josef Pleticha +4 more
2015Cancer Genetics73 citations
Semantic Scholar
Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance)
Ganesh K. Boora, R. Kanwar, A. Kulkarni, A. Abyzov +5 more
2016Cancer Medicine48 citations Open access
Semantic Scholar
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
Z. Bakouny, C. Labaki, P. Grover, J. Awosika +72 more
2022JAMA Oncology45 citations Open access
Semantic Scholar
Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance)
Ganesh K. Boora, A. Kulkarni, R. Kanwar, P. Beyerlein +9 more
2015Journal of Neurological Sciences45 citations Open access
Semantic Scholar
Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis
Shi-Jia Zhang, A. Kulkarni, Beibei Xu, H. Chu +5 more
2020Blood Cancer Journal40 citations Open access
Semantic Scholar
Comparative analysis of antibiotic exposure association with clinical outcomes of chemotherapy versus immunotherapy across three tumour types
A. Kulkarni, M. Ebadi, Shi-Jia Zhang, M. A. Meybodi +8 more
2020ESMO Open30 citations Open access
Semantic Scholar
A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance
M. Abidi, D. Aboulafia, M. Accordino, J. Acoba +278 more
2020Cancer Cell26 citations Open access
Semantic Scholar
Neurotoxicity to DRG Neurons Varies Between Rodent Strains Treated with Cisplatin and Bortezomib
J. Podratz, A. Kulkarni, Josef Pleticha, R. Kanwar +3 more
2015Journal of Neurological Sciences26 citations Open access
Semantic Scholar
The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19
Ang Li, N. Kuderer, Chih-Yuan Hsu, Y. Shyr +33 more
2021Journal of Thrombosis and Haemostasis25 citations Open access
Semantic Scholar
Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer
Shi-Jia Zhang, D. Pease, A. Kulkarni, Manoj Kumar +4 more
2021Clinical Medicine Insights: Oncology24 citations Open access
Semantic Scholar
Risk for stroke and myocardial infarction with abiraterone versus enzalutamide in metastatic prostate cancer patients
A. Kulkarni, N. Rubin, A. Tholkes, S. Shah +4 more
2021ESMO Open23 citations Open access
Semantic Scholar
Impact of antibiotics and proton pump inhibitors on clinical outcomes of immune check point blockers in advanced non-small cell lung cancers and metastatic renal cell cancer.
A. Kulkarni, Manoj Kumar, D. Pease, Ying Wang +2 more
2019Journal of Clinical Oncology19 citations
Semantic Scholar
Nonlinear association between body mass index and overall survival in advanced NSCLC patients treated with immune checkpoint blockade
Aditya Jain, Shi-Jia Zhang, R. Shanley, N. Fujioka +3 more
2022Cancer Immunology and Immunotherapy15 citations Open access
Semantic Scholar
Real-world multiomic characterization of small cell lung cancer subtypes to reveal differential expression of clinically relevant biomarkers.
Sonam Puri, A. Naqash, A. Elliott, K. Kerrigan +14 more
2021Journal of Clinical Oncology12 citations
Semantic Scholar
Is It Time to Implement Adjuvant Targeted Therapy in EGFR-Mutant Non-Small-Cell Lung Cancer?
A. Kulkarni, A. Naqash, Sonam Puri, R. Dienstmann
2021JCO Precision Oncology11 citations Open access
Semantic Scholar
RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial N08C1
A. Kulkarni, Ganesh K. Boora, R. Kanwar, K. Ruddy +5 more
2014Acta oncologica11 citations Open access
Semantic Scholar
Resistance to EGFR Tyrosine Kinase Inhibitor Therapy in Non-Small-Cell Lung Cancer via Newly Acquired Targetable Oncogenic Driver Alterations With an Emphasis on BRAF: Case Series and Literature Review of Treatment.
N. Giustini, S. Patel, N. Myall, José Fernando Do Prado Moura +4 more
2022JCO Precision Oncology10 citations
Semantic Scholar
Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry
Ang Li, N. Kuderer, J. Warner, A. Desai +27 more
2020Blood7 citations Open access
Semantic Scholar
Mortality from COVID-19 in patients with lung cancer
A. Kulkarni, G. Wilson, N. Fujioka, Manish R Patel
2021Journal of Cancer Metastasis and Treatment5 citations Open access
Semantic Scholar
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study
M. Wagner, C. Hennessy, A. Beeghly, B. French +43 more
2022Cancers4 citations Open access
Semantic Scholar
MA07.09 Impact of Body Mass Index on Clinical Outcomes of Immune Checkpoint Blockers in Advanced Non-Small Cell Lung Cancer
A. Kulkarni, Shi-Jia Zhang, T. Defor, M. Patel
2019Journal of Thoracic Oncology3 citations Open access
Semantic Scholar
Abstract LB-196: Sequencing symptom control: Results from the Alliance N08C1 and N08CA genetics of chemotherapy neuropathy trials.
A. Beutler, A. Kulkarni, R. Kanwar, R. Qin +3 more
20133 citations
Semantic Scholar
Exceptional response to afatinib in a patient with persistent G719A EGFR-mutant NSCLC
A. Kulkarni, N. Fujioka, L. Reinhardt, Manish R Patel +1 more
2022Lung Cancer Management2 citations Open access
Semantic Scholar
A Turning Point for Mesothelioma Therapy.
A. Kulkarni, R. Kratzke
2021JCO Oncology Practice2 citations Open access
Semantic Scholar
Thrombotic complications with SARS-CoV-2 infection in patients with cancer on high-risk therapies: Data from the COVID-19 and Cancer Consortium (CCC19).
S. Gulati, Surbhi Shah, A. Kulkarni, A. Desai +16 more
2021Journal of Clinical Oncology2 citations
Semantic Scholar
Clinical Trial End Points in Severe COVID-19
A. Desai, A. Kulkarni, S. V. Rajkumar, B. Gyawali
2020Mayo Clinic proceedings2 citations Open access
Semantic Scholar
Real-world cardiovascular outcomes with novel anti-androgen agents in prostate cancer patients.
A. Kulkarni, N. Rubin, T. Tholkes, A. Prizment +2 more
2019Journal of Clinical Oncology2 citations
Semantic Scholar
Wilson's Disease
A. Kulkarni, V. Sharma
20171 citations
Semantic Scholar
Impact of CLEC3B mRNA expression on genetic landscape and immune tumor-microenvironment in NSCLC.
K. Zimmer, F. Kocher, P. Tymoszuk, A. Martowicz +16 more
2023Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Association of cannabis use with real-world time to treatment discontinuation (rwTTD) in patients with advanced cancer initiating immune checkpoint inhibition (ICI).
Dylan M. Zylla, Greg Knowlton, G. Gilmore, P. Pawloski +4 more
2023Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Surfaceome profiling to reveal unique therapeutic vulnerabilities in transcriptional subtypes of small cell lung cancer (SCLC).
T. Owonikoko, A. Elliott, B. Dwivedi, A. Ivanov +16 more
2022Journal of Clinical Oncology0 citations
Semantic Scholar
Impact of antibiotics on residual cancer burden and pathologic response rates during neoadjuvant pembrolizumab in breast cancer (BC).
A. Kulkarni, Patricia I. Jewett, A. Blaes, D. Yee
20200 citations
Semantic Scholar
Advancing precision medicine in clinical oncology: Whole exome paired tumor-normal DNA and RNA sequencing at a single-institution cancer center.
K. McDonnell, A. Kulkarni, Melissa Woodhouse, Sidney A Smith +14 more
20200 citations
Semantic Scholar
Cryptococcus Infection and Lymphocytopenia: An Ill Defined Entity
Venkat Reddy, S. Brund, A. Kulkarni, B. Keshava
2019Journal of Clinical and Diagnostic Research0 citations Open access
Semantic Scholar
CDKN1B SINET Ng.2821
J. Francis, Adam Kiezun, A. Ramos, S. Serra +43 more
20130 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Kanwar×9
Invite
R. Kanwar — researcher profile on SciRah
A. Beutler×9
Invite
A. Beutler — researcher profile on SciRah
Michaela S. Banck×7
Invite
Michaela S. Banck — researcher profile on SciRah
A. Desai×6
Invite
A. Desai — researcher profile on SciRah

×6

Invite

D. Shah — researcher profile on SciRah

Invite

B. Halmos — researcher profile on SciRah

Ganesh K. Boora×5

Invite

Ganesh K. Boora — researcher profile on SciRah

Invite

S. Gulati — researcher profile on SciRah

Invite

C. Hwang — researcher profile on SciRah

Invite

R. McKay — researcher profile on SciRah

Shi-Jia Zhang×5

Invite

Shi-Jia Zhang — researcher profile on SciRah

Invite

P. Grivas — researcher profile on SciRah